SUANFARMA founded in 1993, is a B2B life science partner specialized in the development, production and commercialization of ingredients for the pharmaceutical, veterinary and nutraceutical industries. Our APIs facilities comply with the highest existing regulations in the pharmaceutical industry and a consolidated and strong commercial network with 12 local offices placed strategically around the world, SUANFARMA provides its services to more than 3.000 active customers in over 70 countries.
At SUANFARMA, we are committed to health and innovation. We develop new technologies and processes to offer innovative products, following the trends of the world of health and the needs of our customers. We cover both “super sales” molecules and niche molecules or specialized therapies.
At SUANFARMA, we are committed to health and innovation. We develop new technologies and processes to offer innovative products, following the trends of the world of health and the needs of our customers. We cover both “super sales” molecules and niche molecules or specialized therapies.
Location: Spain, Community of Madrid, San Fernando de Henares
Employees: 501-1000
Founded date: 1993
Investors 1
| Date | Name | Website |
| - | ArchiMed | archimed.g... |
Mentions in press and media 4
| Date | Title | Description |
| 21.09.2021 | El fondo francés Archimed adquiere Suanfarma. ICG y ProA desinvierten su participación | 21/09/2021 ARCHIMED ADQUIERE SUANFARMA. ICG Y PROA DESINVIERTEN SU PARTICIPACIÓN. El fondo de capital riesgo francés ArchiMed desembarcará en España con la compra de entre un 80-85% de la farmacéutica Suanfarma en una operación que podría... |
| 15.11.2017 | Suanfarma, participada por ProA Capital, adquiere una participación mayoritaria en Productos Químicos Gonmisol | 15/11/2017 SUANFARMA, PARTICIPADA POR PROA CAPITAL, ADQUIERE UNA PARTICIPACIÓN MAYORITARIA EN PRODUCTOS QUIÍMICOS GONMISOL. Suanfarma, participada por la entidad de capital riesgo (private equity) ProA Capital, ha adquirido una participac... |
| 29.09.2016 | Suanfarma adquiere la cotizada biotecnológica CIPAN en Portugal | 29/09/2016 SUANFARMA ADQUIERE LA COTIZADA BIOTECNOLÓGICA CIPAN EN PORTUGAL. Suanfarma ha completado la adquisición de la Compañía Industrial Productora de Antibióticos (CIPAN) en Portugal. CIPAN, firma de gran prestigio internacional y pi... |
| 13.09.2016 | Idifarma, participada por Sodena, incorpora a Suanfarma para impulsar su crecimiento internacional | 13/09/2016 IDIFARMA, PARTICIPADA POR SODENA, INCORPORA EN SU ESTRUCTURA SOCIETARIA A SUANFARMA PARA IMPULSAR SU CRECIMIENTO INTERNACIONAL. Como parte de un proceso previsto de sustitución de socios financieros de capital riesgo, Idifarma ... |